A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)
Status:
Completed
Trial end date:
2023-11-21
Target enrollment:
Participant gender:
Summary
This trial will evaluate the effects of Lu AF28996 in adult Japanese men and women with
Parkinson's disease (PD). The main goals of the trial are to learn more about a) the safety
and tolerability of Lu AF28996 (any new or worsening medical issues the participants have
with treatment), and b) the pharmacokinetic parameters of Lu AF28996 (how the drug is
absorbed, distributed, and processed by the body). Participants will take Lu AF28996 capsules
orally once a day (OD). The participants will start with a low dose of Lu AF28996, which will
be increased gradually over a period of 2 weeks, and then decreased gradually over a period
of about 2 weeks.